ID   SC6A4_HUMAN             Reviewed;         630 AA.
AC   P31645; Q5EE02;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   10-MAY-2017, entry version 170.
DE   RecName: Full=Sodium-dependent serotonin transporter;
DE            Short=SERT {ECO:0000250|UniProtKB:P31652};
DE   AltName: Full=5HT transporter;
DE            Short=5HTT;
DE   AltName: Full=Solute carrier family 6 member 4;
GN   Name=SLC6A4; Synonyms=HTT, SERT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=8452685; DOI=10.1007/BF01244919;
RA   Lesch K.P., Wolozin B.L., Estler H.C., Murphy D.L., Riederer P.;
RT   "Isolation of a cDNA encoding the human brain serotonin transporter.";
RL   J. Neural Transm. 91:67-73(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=7681602; DOI=10.1073/pnas.90.6.2542;
RA   Ramamoorthy S., Bauman A.L., Moore K.R., Han H., Yang-Feng T.,
RA   Chang A.S., Ganapathy V., Blakely R.D.;
RT   "Antidepressant- and cocaine-sensitive human serotonin transporter:
RT   molecular cloning, expression, and chromosomal localization.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:2542-2546(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Platelet;
RX   PubMed=7684072; DOI=10.1111/j.1471-4159.1993.tb03522.x;
RA   Lesch K.P., Wolozin B.L., Murphy D.L., Reiderer P.;
RT   "Primary structure of the human platelet serotonin uptake site:
RT   identity with the brain serotonin transporter.";
RL   J. Neurochem. 60:2319-2322(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=16601320;
RA   Iceta R., Mesonero J.E., Aramayona J.J., Alcalde A.I.;
RT   "Molecular characterization and intracellular regulation of the human
RT   serotonin transporter in Caco-2 cells.";
RL   J. Physiol. Pharmacol. 57:119-130(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (AUG-2007) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-114.
RC   TISSUE=Placenta;
RA   Bradley C.C., Blakely R.D.;
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-317 (ISOFORM 2).
RC   TISSUE=Lung;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   INTERACTION WITH TGFB1I1.
RX   PubMed=16803896; DOI=10.1074/jbc.M603877200;
RA   Carneiro A.M.D., Blakely R.D.;
RT   "Serotonin-, protein kinase C-, and Hic-5-associated redistribution of
RT   the platelet serotonin transporter.";
RL   J. Biol. Chem. 281:24769-24780(2006).
RN   [10]
RP   INTERACTION WITH SCAMP2, AND SUBCELLULAR LOCATION.
RX   PubMed=16870614; DOI=10.1074/jbc.M602848200;
RA   Mueller H.K., Wiborg O., Haase J.;
RT   "Subcellular redistribution of the serotonin transporter by secretory
RT   carrier membrane protein 2.";
RL   J. Biol. Chem. 281:28901-28909(2006).
RN   [11]
RP   FUNCTION, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=17506858; DOI=10.1111/j.1471-4159.2007.04542.x;
RA   Brenner B., Harney J.T., Ahmed B.A., Jeffus B.C., Unal R., Mehta J.L.,
RA   Kilic F.;
RT   "Plasma serotonin levels and the platelet serotonin transporter.";
RL   J. Neurochem. 102:206-215(2007).
RN   [12]
RP   PHOSPHORYLATION AT THR-276, AND VARIANT VAL-425.
RX   PubMed=17913921; DOI=10.1523/JNEUROSCI.0034-07.2007;
RA   Zhang Y.W., Gesmonde J., Ramamoorthy S., Rudnick G.;
RT   "Serotonin transporter phosphorylation by cGMP-dependent protein
RT   kinase is altered by a mutation associated with obsessive compulsive
RT   disorder.";
RL   J. Neurosci. 27:10878-10886(2007).
RN   [13]
RP   FUNCTION, INTERACTION WITH RAB4, SUBCELLULAR LOCATION, AND INDUCTION
RP   BY SEROTONIN.
RX   PubMed=18227069; DOI=10.1074/jbc.M706367200;
RA   Ahmed B.A., Jeffus B.C., Bukhari S.I., Harney J.T., Unal R.,
RA   Lupashin V.V., van der Sluijs P., Kilic F.;
RT   "Serotonin transamidates Rab4 and facilitates its binding to the C
RT   terminus of serotonin transporter.";
RL   J. Biol. Chem. 283:9388-9398(2008).
RN   [14]
RP   FUNCTION, INTERACTION WITH VIM, SUBCELLULAR LOCATION, INDUCTION BY
RP   SEROTONIN, MUTAGENESIS OF SER-611; THR-613 AND THR-616, AND
RP   PHOSPHORYLATION AT SER-611; THR-613 AND THR-616.
RX   PubMed=19270731; DOI=10.1371/journal.pone.0004730;
RA   Ahmed B.A., Bukhari I.A., Jeffus B.C., Harney J.T., Thyparambil S.,
RA   Ziu E., Fraer M., Rusch N.J., Zimniak P., Lupashin V., Tang D.,
RA   Kilic F.;
RT   "The cellular distribution of serotonin transporter is impeded on
RT   serotonin-altered vimentin network.";
RL   PLoS ONE 4:E4730-E4730(2009).
RN   [15]
RP   PHOSPHORYLATION AT TYR-47 AND TYR-142.
RX   PubMed=21992875; DOI=10.1124/mol.111.073171;
RA   Annamalai B., Mannangatti P., Arapulisamy O., Shippenberg T.S.,
RA   Jayanthi L.D., Ramamoorthy S.;
RT   "Tyrosine phosphorylation of the human serotonin transporter: a role
RT   in the transporter stability and function.";
RL   Mol. Pharmacol. 81:73-85(2012).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (3.14 ANGSTROMS) OF 76-618 IN COMPLEXES WITH
RP   SODIUM IONS AND THE ANTIDEPRESSANTS CITALOPRAM AND PAROXETINE,
RP   FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY, GLYCOSYLATION AT ASN-208 AND
RP   ASN-217, AND DISULFIDE BONDS.
RX   PubMed=27049939; DOI=10.1038/nature17629;
RA   Coleman J.A., Green E.M., Gouaux E.;
RT   "X-ray structures and mechanism of the human serotonin transporter.";
RL   Nature 532:334-339(2016).
RN   [17]
RP   VARIANTS ALA-56 AND ASN-605.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [18]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
RN   [19]
RP   VARIANT VAL-425.
RX   PubMed=14593431; DOI=10.1038/sj.mp.4001365;
RA   Ozaki N., Goldman D., Kaye W.H., Plotnicov K., Greenberg B.D.,
RA   Lappalainen J., Rudnick G., Murphy D.L.;
RT   "Serotonin transporter missense mutation associated with a complex
RT   neuropsychiatric phenotype.";
RL   Mol. Psychiatry 8:933-936(2003).
RN   [20]
RP   CHARACTERIZATION OF VARIANT VAL-425.
RX   PubMed=12869649; DOI=10.1124/mol.64.2.440;
RA   Kilic F., Murphy D.L., Rudnick G.;
RT   "A human serotonin transporter mutation causes constitutive activation
RT   of transport activity.";
RL   Mol. Pharmacol. 64:440-446(2003).
RN   [21]
RP   POLYMORPHISM IN THE PROMOTER REGION.
RX   PubMed=12869766; DOI=10.1126/science.1083968;
RA   Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W.,
RA   Harrington H., McClay J., Mill J., Martin J., Braithwaite A.,
RA   Poulton R.;
RT   "Influence of life stress on depression: moderation by a polymorphism
RT   in the 5-HTT gene.";
RL   Science 301:386-389(2003).
RN   [22]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO ALCOHOLISM.
RX   PubMed=15635638; DOI=10.1002/ajmg.b.30132;
RA   Feinn R., Nellissery M., Kranzler H.R.;
RT   "Meta-analysis of the association of a functional serotonin
RT   transporter promoter polymorphism with alcohol dependence.";
RL   Am. J. Med. Genet. B Neuropsychiatr. Genet. 133:79-84(2005).
CC   -!- FUNCTION: Serotonin transporter whose primary function in the
CC       central nervous system involves the regulation of serotonergic
CC       signaling via transport of serotonin molecules from the synaptic
CC       cleft back into the pre-synaptic terminal for re-utilization.
CC       Plays a key role in mediating regulation of the availability of
CC       serotonin to other receptors of serotonergic systems. Terminates
CC       the action of serotonin and recycles it in a sodium-dependent
CC       manner. {ECO:0000269|PubMed:17506858, ECO:0000269|PubMed:18227069,
CC       ECO:0000269|PubMed:19270731, ECO:0000269|PubMed:27049939}.
CC   -!- SUBUNIT: Monomer or homooligomer (By similarity). Interacts with
CC       TGFB1I1. Interacts (via sialylated form) with MYH9. Interacts with
CC       SEC23A, SEC24C and PATJ. Interacts with NOS1; the interaction may
CC       diminish the cell surface localization of SERT in the brain and,
CC       correspondingly, reduce serotonin reuptake. Interacts with
CC       filamentous actin and STX1A (By similarity). Interacts (via C-
CC       terminus) with VIM. Interacts (via C-terminus) with SCAMP2; the
CC       interaction is direct and retains transporter molecules
CC       intracellularly. Interacts with RAB4 (GTP-bound form); the
CC       interaction retains transporter molecules intracellularly.
CC       {ECO:0000250, ECO:0000269|PubMed:16803896,
CC       ECO:0000269|PubMed:16870614, ECO:0000269|PubMed:18227069,
CC       ECO:0000269|PubMed:19270731}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16870614,
CC       ECO:0000269|PubMed:17506858, ECO:0000269|PubMed:18227069,
CC       ECO:0000269|PubMed:19270731, ECO:0000269|PubMed:27049939}; Multi-
CC       pass membrane protein {ECO:0000250|UniProtKB:Q7K4Y6,
CC       ECO:0000269|PubMed:27049939}. Endomembrane system
CC       {ECO:0000269|PubMed:16870614}; Multi-pass membrane protein
CC       {ECO:0000255}. Endosome membrane {ECO:0000269|PubMed:16870614,
CC       ECO:0000269|PubMed:18227069}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Could be part of recycling endosomes
CC       (PubMed:18227069, PubMed:16870614). Density of transporter
CC       molecules on the plasma membrane is itself regulated by STX1A (By
CC       similarity). Density of transporter molecules on the plasma
CC       membrane is also regulated by serotonin (PubMed:17506858)
CC       (PubMed:18227069). {ECO:0000250|UniProtKB:P31652,
CC       ECO:0000269|PubMed:16870614, ECO:0000269|PubMed:17506858,
CC       ECO:0000269|PubMed:18227069}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P31645-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P31645-2; Sequence=VSP_046553;
CC   -!- TISSUE SPECIFICITY: Expressed in platelets (at protein level).
CC       {ECO:0000269|PubMed:17506858}.
CC   -!- INDUCTION: Down-regulated when plasma serotonin is elevated.
CC       {ECO:0000269|PubMed:18227069, ECO:0000269|PubMed:19270731}.
CC   -!- PTM: Glycosylated; modification with sialylated N-glycans is a
CC       requirement for transporters to associate with each other and to
CC       function as homooligomeric forms. {ECO:0000250}.
CC   -!- PTM: Phosphorylation at Thr-276 increases 5-HT uptake and is
CC       required for cGMP-mediated SERT regulation. Phosphorylation upon
CC       PKC stimulation modifies the SERT distribution and density in the
CC       membrane, and diminishes the uptake capacity.
CC       {ECO:0000269|PubMed:17913921, ECO:0000269|PubMed:19270731,
CC       ECO:0000269|PubMed:21992875}.
CC   -!- POLYMORPHISM: A polymorphism in the promoter region (5-HTT gene-
CC       linked polymorphic region, 5-HTTLPR) is located approximately 1 kb
CC       upstream of the transcription initiation site and is composed of
CC       16 repeat elements. The polymorphism consists of a 44-bp insertion
CC       or deletion involving repeat elements 6 to 8. The short allele is
CC       associated with lower transcriptional efficiency of the promoter
CC       compared with the long allele. Over half of the Caucasian
CC       population has a short allele. Individuals with one or two copies
CC       of the short allele exhibit more depressive symptoms, diagnosable
CC       depression and suicidality in relation to stressful life events
CC       than individuals homozygous for the long allele.
CC       {ECO:0000269|PubMed:12869766}.
CC   -!- POLYMORPHISM: The polymorphism Val-425 seems to be linked to a
CC       susceptibility to obsessive-compulsive disorder (OCD)
CC       [MIM:164230]. {ECO:0000269|PubMed:12869649,
CC       ECO:0000269|PubMed:14593431, ECO:0000269|PubMed:17913921}.
CC   -!- POLYMORPHISM: Genetic variations in SLC6A4 determine the genetic
CC       susceptibility to alcoholism [MIM:103780].
CC       {ECO:0000269|PubMed:15635638}.
CC   -!- MISCELLANEOUS: This protein is the target of psychomotor
CC       stimulants such as amphetamines or cocaine.
CC   -!- SIMILARITY: Belongs to the sodium:neurotransmitter symporter (SNF)
CC       (TC 2.A.22) family. SLC6A4 subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=SLC6A4";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Serotonin transporter entry;
CC       URL="https://en.wikipedia.org/wiki/Serotonin_transporter";
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Love, love, love...
CC       -Issue 123 of November 2010;
CC       URL="http://web.expasy.org/spotlight/back_issues/123";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/slc6a4/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X70697; CAA50029.1; -; mRNA.
DR   EMBL; L05568; AAA35492.1; -; mRNA.
DR   EMBL; AY902473; AAW80933.1; -; mRNA.
DR   EMBL; EU099989; ABV02581.1; -; Genomic_DNA.
DR   EMBL; BC069484; AAH69484.1; -; mRNA.
DR   EMBL; U79746; AAB93475.1; -; Genomic_DNA.
DR   EMBL; AK308014; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS11256.1; -. [P31645-1]
DR   PIR; A47398; A47398.
DR   RefSeq; NP_001036.1; NM_001045.5. [P31645-1]
DR   UniGene; Hs.134662; -.
DR   UniGene; Hs.29792; -.
DR   PDB; 5I6X; X-ray; 3.14 A; A=76-618.
DR   PDB; 5I6Z; X-ray; 4.53 A; A=76-618.
DR   PDB; 5I71; X-ray; 3.15 A; A=76-618.
DR   PDB; 5I73; X-ray; 3.24 A; A=76-618.
DR   PDB; 5I74; X-ray; 3.40 A; A=76-618.
DR   PDB; 5I75; X-ray; 3.49 A; A=76-618.
DR   PDBsum; 5I6X; -.
DR   PDBsum; 5I6Z; -.
DR   PDBsum; 5I71; -.
DR   PDBsum; 5I73; -.
DR   PDBsum; 5I74; -.
DR   PDBsum; 5I75; -.
DR   ProteinModelPortal; P31645; -.
DR   SMR; P31645; -.
DR   BioGrid; 112423; 5.
DR   IntAct; P31645; 2.
DR   MINT; MINT-577123; -.
DR   STRING; 9606.ENSP00000261707; -.
DR   BindingDB; P31645; -.
DR   ChEMBL; CHEMBL228; -.
DR   DrugBank; DB01472; 4-Methoxyamphetamine.
DR   DrugBank; DB04836; Amineptine.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB00543; Amoxapine.
DR   DrugBank; DB00182; Amphetamine.
DR   DrugBank; DB00289; Atomoxetine.
DR   DrugBank; DB04889; Bicifadine.
DR   DrugBank; DB09016; Butriptyline.
DR   DrugBank; DB01114; Chlorphenamine.
DR   DrugBank; DB00215; Citalopram.
DR   DrugBank; DB01242; Clomipramine.
DR   DrugBank; DB00907; Cocaine.
DR   DrugBank; DB05688; CRx-119.
DR   DrugBank; DB01151; Desipramine.
DR   DrugBank; DB06700; Desvenlafaxine.
DR   DrugBank; DB01191; Dexfenfluramine.
DR   DrugBank; DB06701; Dexmethylphenidate.
DR   DrugBank; DB00514; Dextromethorphan.
DR   DrugBank; DB00988; Dopamine.
DR   DrugBank; DB01142; Doxepin.
DR   DrugBank; DB00476; Duloxetine.
DR   DrugBank; DB01363; Ephedra.
DR   DrugBank; DB01175; Escitalopram.
DR   DrugBank; DB00574; Fenfluramine.
DR   DrugBank; DB00472; Fluoxetine.
DR   DrugBank; DB00176; Fluvoxamine.
DR   DrugBank; DB00458; Imipramine.
DR   DrugBank; DB08918; Levomilnacipran.
DR   DrugBank; DB00408; Loxapine.
DR   DrugBank; DB00579; Mazindol.
DR   DrugBank; DB01577; Methamphetamine.
DR   DrugBank; DB00422; Methylphenidate.
DR   DrugBank; DB06148; Mianserin.
DR   DrugBank; DB04896; Milnacipran.
DR   DrugBank; DB00805; Minaprine.
DR   DrugBank; DB00370; Mirtazapine.
DR   DrugBank; DB01442; MMDA.
DR   DrugBank; DB01149; Nefazodone.
DR   DrugBank; DB00540; Nortriptyline.
DR   DrugBank; DB05422; OPC-14523.
DR   DrugBank; DB00715; Paroxetine.
DR   DrugBank; DB00454; Pethidine.
DR   DrugBank; DB00191; Phentermine.
DR   DrugBank; DB00344; Protriptyline.
DR   DrugBank; DB00852; Pseudoephedrine.
DR   DrugBank; DB01104; Sertraline.
DR   DrugBank; DB01105; Sibutramine.
DR   DrugBank; DB06204; Tapentadol.
DR   DrugBank; DB01079; Tegaserod.
DR   DrugBank; DB00193; Tramadol.
DR   DrugBank; DB00656; Trazodone.
DR   DrugBank; DB00726; Trimipramine.
DR   DrugBank; DB00285; Venlafaxine.
DR   DrugBank; DB00661; Verapamil.
DR   DrugBank; DB06684; Vilazodone.
DR   DrugBank; DB09068; Vortioxetine.
DR   DrugBank; DB04832; Zimelidine.
DR   GuidetoPHARMACOLOGY; 928; -.
DR   TCDB; 2.A.22.1.1; the neurotransmitter:sodium symporter (nss) family.
DR   iPTMnet; P31645; -.
DR   PhosphoSitePlus; P31645; -.
DR   DMDM; 400630; -.
DR   PaxDb; P31645; -.
DR   PeptideAtlas; P31645; -.
DR   PRIDE; P31645; -.
DR   Ensembl; ENST00000261707; ENSP00000261707; ENSG00000108576. [P31645-1]
DR   Ensembl; ENST00000401766; ENSP00000385822; ENSG00000108576. [P31645-1]
DR   GeneID; 6532; -.
DR   KEGG; hsa:6532; -.
DR   UCSC; uc002hey.6; human. [P31645-1]
DR   CTD; 6532; -.
DR   DisGeNET; 6532; -.
DR   GeneCards; SLC6A4; -.
DR   HGNC; HGNC:11050; SLC6A4.
DR   HPA; HPA054723; -.
DR   HPA; HPA074728; -.
DR   MalaCards; SLC6A4; -.
DR   MIM; 103780; phenotype.
DR   MIM; 164230; phenotype.
DR   MIM; 182138; gene.
DR   neXtProt; NX_P31645; -.
DR   OpenTargets; ENSG00000108576; -.
DR   PharmGKB; PA312; -.
DR   eggNOG; KOG3659; Eukaryota.
DR   eggNOG; COG0733; LUCA.
DR   GeneTree; ENSGT00760000118857; -.
DR   HOGENOM; HOG000116406; -.
DR   HOVERGEN; HBG071421; -.
DR   InParanoid; P31645; -.
DR   KO; K05037; -.
DR   OMA; CRDVKEM; -.
DR   OrthoDB; EOG091G08PX; -.
DR   PhylomeDB; P31645; -.
DR   TreeFam; TF343812; -.
DR   Reactome; R-HSA-380615; Serotonin clearance from the synaptic cleft.
DR   SIGNOR; P31645; -.
DR   GeneWiki; Serotonin_transporter; -.
DR   GenomeRNAi; 6532; -.
DR   PRO; PR:P31645; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000108576; -.
DR   CleanEx; HS_HTT; -.
DR   CleanEx; HS_SLC6A4; -.
DR   ExpressionAtlas; P31645; baseline and differential.
DR   Genevisible; P31645; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0012505; C:endomembrane system; IDA:UniProtKB.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0051015; F:actin filament binding; ISS:UniProtKB.
DR   GO; GO:0019811; F:cocaine binding; IEA:Ensembl.
DR   GO; GO:0005330; F:dopamine:sodium symporter activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008504; F:monoamine transmembrane transporter activity; IDA:MGI.
DR   GO; GO:0017022; F:myosin binding; IEA:Ensembl.
DR   GO; GO:0050998; F:nitric-oxide synthase binding; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0017137; F:Rab GTPase binding; IPI:UniProtKB.
DR   GO; GO:0015222; F:serotonin transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005335; F:serotonin:sodium symporter activity; IDA:UniProtKB.
DR   GO; GO:0017075; F:syntaxin-1 binding; IEA:Ensembl.
DR   GO; GO:0048854; P:brain morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0071321; P:cellular response to cGMP; IEA:Ensembl.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl.
DR   GO; GO:0007623; P:circadian rhythm; IEA:Ensembl.
DR   GO; GO:0051583; P:dopamine uptake involved in synaptic transmission; IBA:GO_Central.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:0015844; P:monoamine transport; IDA:MGI.
DR   GO; GO:0021941; P:negative regulation of cerebellar granule cell precursor proliferation; IEA:Ensembl.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0046621; P:negative regulation of organ growth; ISS:BHF-UCL.
DR   GO; GO:0032227; P:negative regulation of synaptic transmission, dopaminergic; IEA:Ensembl.
DR   GO; GO:0042136; P:neurotransmitter biosynthetic process; TAS:Reactome.
DR   GO; GO:0045787; P:positive regulation of cell cycle; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0014064; P:positive regulation of serotonin secretion; IEA:Ensembl.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:Ensembl.
DR   GO; GO:0051259; P:protein oligomerization; ISS:UniProtKB.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   GO; GO:0009636; P:response to toxic substance; IDA:UniProtKB.
DR   GO; GO:0006837; P:serotonin transport; IDA:UniProtKB.
DR   GO; GO:0051610; P:serotonin uptake; IDA:UniProtKB.
DR   GO; GO:0035176; P:social behavior; ISS:BHF-UCL.
DR   GO; GO:0042713; P:sperm ejaculation; IEA:Ensembl.
DR   GO; GO:0021794; P:thalamus development; IMP:UniProtKB.
DR   GO; GO:0042310; P:vasoconstriction; IEA:Ensembl.
DR   InterPro; IPR000175; Na/ntran_symport.
DR   InterPro; IPR013086; Na/ntran_symport_serotonin_N.
DR   PANTHER; PTHR11616; PTHR11616; 1.
DR   Pfam; PF03491; 5HT_transport_N; 1.
DR   Pfam; PF00209; SNF; 1.
DR   PRINTS; PR01203; 5HTTRANSPORT.
DR   PRINTS; PR00176; NANEUSMPORT.
DR   PROSITE; PS00610; NA_NEUROTRAN_SYMP_1; 1.
DR   PROSITE; PS00754; NA_NEUROTRAN_SYMP_2; 1.
DR   PROSITE; PS50267; NA_NEUROTRAN_SYMP_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; Endosome; Glycoprotein; Membrane; Metal-binding;
KW   Neurotransmitter transport; Phosphoprotein; Polymorphism;
KW   Reference proteome; Sodium; Symport; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    630       Sodium-dependent serotonin transporter.
FT                                /FTId=PRO_0000214757.
FT   TOPO_DOM      1     87       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM     88    112       Helical; Name=1.
FT                                {ECO:0000269|PubMed:27049939}.
FT   TOPO_DOM    113    115       Extracellular. {ECO:0000305}.
FT   TRANSMEM    116    135       Helical; Name=2.
FT                                {ECO:0000269|PubMed:27049939}.
FT   TOPO_DOM    136    160       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    161    186       Helical; Name=3.
FT                                {ECO:0000269|PubMed:27049939}.
FT   TOPO_DOM    187    252       Extracellular. {ECO:0000305}.
FT   TRANSMEM    253    271       Helical; Name=4.
FT                                {ECO:0000269|PubMed:27049939}.
FT   TOPO_DOM    272    277       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    278    297       Helical; Name=5.
FT                                {ECO:0000269|PubMed:27049939}.
FT   TOPO_DOM    298    324       Extracellular. {ECO:0000305}.
FT   TRANSMEM    325    347       Helical; Name=6.
FT                                {ECO:0000269|PubMed:27049939}.
FT   TOPO_DOM    348    360       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    361    380       Helical; Name=7.
FT                                {ECO:0000269|PubMed:27049939}.
FT   TOPO_DOM    381    421       Extracellular. {ECO:0000305}.
FT   TRANSMEM    422    443       Helical; Name=8.
FT                                {ECO:0000269|PubMed:27049939}.
FT   TOPO_DOM    444    463       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    464    483       Helical; Name=9.
FT                                {ECO:0000269|PubMed:27049939}.
FT   TOPO_DOM    484    494       Extracellular. {ECO:0000305}.
FT   TRANSMEM    495    516       Helical; Name=10.
FT                                {ECO:0000269|PubMed:27049939}.
FT   TOPO_DOM    517    538       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    539    558       Helical; Name=11.
FT                                {ECO:0000269|PubMed:27049939}.
FT   TOPO_DOM    559    574       Extracellular. {ECO:0000305}.
FT   TRANSMEM    575    595       Helical; Name=12.
FT                                {ECO:0000269|PubMed:27049939}.
FT   TOPO_DOM    596    630       Cytoplasmic. {ECO:0000305}.
FT   REGION      611    630       Required for serotonin uptake activity.
FT                                {ECO:0000269|PubMed:19270731}.
FT   REGION      616    624       Interaction with RAB4A.
FT   METAL        94     94       Sodium 1; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   METAL        96     96       Sodium 2; via carbonyl oxygen.
FT                                {ECO:0000305|PubMed:27049939}.
FT   METAL        97     97       Sodium 1; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   METAL       101    101       Sodium 2. {ECO:0000305|PubMed:27049939}.
FT   METAL       336    336       Sodium 2. {ECO:0000305|PubMed:27049939}.
FT   METAL       368    368       Sodium 2. {ECO:0000305|PubMed:27049939}.
FT   METAL       434    434       Sodium 1; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   METAL       437    437       Sodium 1. {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   METAL       438    438       Sodium 1. {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   MOD_RES      47     47       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:21992875}.
FT   MOD_RES     142    142       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:21992875}.
FT   MOD_RES     276    276       Phosphothreonine; by PKG.
FT                                {ECO:0000269|PubMed:17913921}.
FT   MOD_RES     611    611       Phosphoserine.
FT                                {ECO:0000269|PubMed:19270731}.
FT   MOD_RES     613    613       Phosphothreonine.
FT                                {ECO:0000269|PubMed:19270731}.
FT   MOD_RES     616    616       Phosphothreonine.
FT                                {ECO:0000269|PubMed:19270731}.
FT   CARBOHYD    208    208       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255,
FT                                ECO:0000269|PubMed:27049939}.
FT   CARBOHYD    217    217       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255,
FT                                ECO:0000269|PubMed:27049939}.
FT   DISULFID    200    209       {ECO:0000244|PDB:5I6X,
FT                                ECO:0000244|PDB:5I6Z,
FT                                ECO:0000244|PDB:5I71,
FT                                ECO:0000244|PDB:5I73,
FT                                ECO:0000244|PDB:5I74,
FT                                ECO:0000244|PDB:5I75}.
FT   VAR_SEQ       1      1       M -> MSQSRRVNPDDRELGGDLQIQAPRDQLGSLADGHQC
FT                                HLLTSRM (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046553.
FT   VARIANT      56     56       G -> A (in dbSNP:rs6355).
FT                                {ECO:0000269|PubMed:10391209}.
FT                                /FTId=VAR_014181.
FT   VARIANT     201    201       K -> N (in dbSNP:rs2228673).
FT                                /FTId=VAR_029158.
FT   VARIANT     425    425       I -> L (in dbSNP:rs28914832).
FT                                /FTId=VAR_036788.
FT   VARIANT     425    425       I -> V (polymorphism linked with
FT                                susceptibility to obsessive-compulsive
FT                                disorder; increased serotonin transport
FT                                capacity; dbSNP:rs28914832).
FT                                {ECO:0000269|PubMed:12869649,
FT                                ECO:0000269|PubMed:14593431,
FT                                ECO:0000269|PubMed:17913921}.
FT                                /FTId=VAR_026751.
FT   VARIANT     465    465       F -> L (in dbSNP:rs28914833).
FT                                /FTId=VAR_036789.
FT   VARIANT     550    550       L -> V (in dbSNP:rs28914834).
FT                                /FTId=VAR_036790.
FT   VARIANT     605    605       K -> N (in dbSNP:rs6352).
FT                                {ECO:0000269|PubMed:10391209}.
FT                                /FTId=VAR_014182.
FT   MUTAGEN     611    611       S->A: Loss of 10 % of serotonin uptake
FT                                activity. Loss of 5 % of serotonin uptake
FT                                activity; when associated with A-613 and
FT                                A-616. {ECO:0000269|PubMed:19270731}.
FT   MUTAGEN     611    611       S->D: Loss of 61 % of serotonin uptake
FT                                activity. Loss of 95 % of serotonin
FT                                uptake activity and lack of association
FT                                between VIM and the plasma membrane; when
FT                                associated with D-613 and D-616.
FT                                {ECO:0000269|PubMed:19270731}.
FT   MUTAGEN     613    613       T->A: Loss of 26 % of serotonin uptake
FT                                activity. Loss of 5 % of serotonin uptake
FT                                activity; when associated with A-611 and
FT                                A-616. {ECO:0000269|PubMed:19270731}.
FT   MUTAGEN     613    613       T->D: Loss of 26 % of serotonin uptake
FT                                activity. Loss of 95 % of serotonin
FT                                uptake activity and lack of association
FT                                between VIM and the plasma membrane; when
FT                                associated with D-611 and D-616.
FT                                {ECO:0000269|PubMed:19270731}.
FT   MUTAGEN     616    616       T->A: No change. Loss of 5 % of serotonin
FT                                uptake activity; when associated with A-
FT                                611 and A-613.
FT                                {ECO:0000269|PubMed:19270731}.
FT   MUTAGEN     616    616       T->D: No change. Loss of 95 % of
FT                                serotonin uptake activity and lack of
FT                                association between VIM and the plasma
FT                                membrane; when associated with D-611 and
FT                                D-613. {ECO:0000269|PubMed:19270731}.
FT   HELIX        85     96       {ECO:0000244|PDB:5I6X}.
FT   HELIX        99    111       {ECO:0000244|PDB:5I6X}.
FT   HELIX       114    117       {ECO:0000244|PDB:5I6X}.
FT   HELIX       118    127       {ECO:0000244|PDB:5I6X}.
FT   HELIX       129    143       {ECO:0000244|PDB:5I6X}.
FT   HELIX       149    152       {ECO:0000244|PDB:5I6X}.
FT   HELIX       156    159       {ECO:0000244|PDB:5I6X}.
FT   HELIX       160    173       {ECO:0000244|PDB:5I6X}.
FT   HELIX       176    188       {ECO:0000244|PDB:5I6X}.
FT   HELIX       189    191       {ECO:0000244|PDB:5I74}.
FT   STRAND      192    194       {ECO:0000244|PDB:5I6X}.
FT   TURN        196    198       {ECO:0000244|PDB:5I6X}.
FT   STRAND      202    204       {ECO:0000244|PDB:5I6X}.
FT   STRAND      207    209       {ECO:0000244|PDB:5I6X}.
FT   STRAND      212    214       {ECO:0000244|PDB:5I6X}.
FT   HELIX       227    234       {ECO:0000244|PDB:5I6X}.
FT   TURN        235    237       {ECO:0000244|PDB:5I74}.
FT   HELIX       239    241       {ECO:0000244|PDB:5I6X}.
FT   STRAND      244    247       {ECO:0000244|PDB:5I6X}.
FT   HELIX       253    270       {ECO:0000244|PDB:5I6X}.
FT   HELIX       274    284       {ECO:0000244|PDB:5I6X}.
FT   HELIX       287    300       {ECO:0000244|PDB:5I6X}.
FT   TURN        303    305       {ECO:0000244|PDB:5I6X}.
FT   HELIX       306    313       {ECO:0000244|PDB:5I6X}.
FT   HELIX       317    321       {ECO:0000244|PDB:5I6X}.
FT   HELIX       323    337       {ECO:0000244|PDB:5I6X}.
FT   STRAND      340    342       {ECO:0000244|PDB:5I71}.
FT   HELIX       343    349       {ECO:0000244|PDB:5I6X}.
FT   STRAND      353    355       {ECO:0000244|PDB:5I6X}.
FT   HELIX       358    389       {ECO:0000244|PDB:5I6X}.
FT   HELIX       396    398       {ECO:0000244|PDB:5I6X}.
FT   HELIX       403    407       {ECO:0000244|PDB:5I6X}.
FT   HELIX       409    415       {ECO:0000244|PDB:5I6X}.
FT   HELIX       420    453       {ECO:0000244|PDB:5I6X}.
FT   HELIX       462    477       {ECO:0000244|PDB:5I6X}.
FT   TURN        478    480       {ECO:0000244|PDB:5I6X}.
FT   HELIX       485    494       {ECO:0000244|PDB:5I6X}.
FT   HELIX       497    513       {ECO:0000244|PDB:5I6X}.
FT   TURN        514    517       {ECO:0000244|PDB:5I6X}.
FT   HELIX       518    528       {ECO:0000244|PDB:5I6X}.
FT   STRAND      529    531       {ECO:0000244|PDB:5I73}.
FT   HELIX       535    542       {ECO:0000244|PDB:5I6X}.
FT   HELIX       544    558       {ECO:0000244|PDB:5I6X}.
FT   HELIX       574    583       {ECO:0000244|PDB:5I6X}.
FT   TURN        584    587       {ECO:0000244|PDB:5I6X}.
FT   HELIX       588    599       {ECO:0000244|PDB:5I6X}.
FT   HELIX       604    612       {ECO:0000244|PDB:5I6X}.
SQ   SEQUENCE   630 AA;  70325 MW;  0EB535B0A579BDA2 CRC64;
     METTPLNSQK QLSACEDGED CQENGVLQKV VPTPGDKVES GQISNGYSAV PSPGAGDDTR
     HSIPATTTTL VAELHQGERE TWGKKVDFLL SVIGYAVDLG NVWRFPYICY QNGGGAFLLP
     YTIMAIFGGI PLFYMELALG QYHRNGCISI WRKICPIFKG IGYAICIIAF YIASYYNTIM
     AWALYYLISS FTDQLPWTSC KNSWNTGNCT NYFSEDNITW TLHSTSPAEE FYTRHVLQIH
     RSKGLQDLGG ISWQLALCIM LIFTVIYFSI WKGVKTSGKV VWVTATFPYI ILSVLLVRGA
     TLPGAWRGVL FYLKPNWQKL LETGVWIDAA AQIFFSLGPG FGVLLAFASY NKFNNNCYQD
     ALVTSVVNCM TSFVSGFVIF TVLGYMAEMR NEDVSEVAKD AGPSLLFITY AEAIANMPAS
     TFFAIIFFLM LITLGLDSTF AGLEGVITAV LDEFPHVWAK RRERFVLAVV ITCFFGSLVT
     LTFGGAYVVK LLEEYATGPA VLTVALIEAV AVSWFYGITQ FCRDVKEMLG FSPGWFWRIC
     WVAISPLFLL FIICSFLMSP PQLRLFQYNY PYWSIILGYC IGTSSFICIP TYIAYRLIIT
     PGTFKERIIK SITPETPTEI PCGDIRLNAV
//
